DIA
Drug Information Association Logo

Pharmacovigilance and Risk Management Strategies 2015

Jan 26 2015 8:30AM - Jan 28 2015 4:00PM | Renaissance Washington DC Downtown Hotel 999 Ninth Street NW Washington, DC 20001

« Back to Listing

Overview 

Tutorials: January 25, 2015
Please monitor the DIA website for tutorial information and registration.


Benefit-Risk in 2015! Regulatory science, tools, realities, and perceptions of biopharmaceutical product benefit-risk continue to evolve across the global pharmacovigilance landscape. During this three-day meeting, thought leaders from around the world will provide their insight and engage in dialogue on current opportunities and challenges in managing product risk in the context of benefit. The current regulatory framework will be outlined and practical approaches to protecting patient safety will be discussed.

This event will provide a unique setting for informal dialogue with representatives from FDA and other key regulatory agencies, as well as from industry and academia. There will be multiple opportunities for participants to engage speakers and interact with fellow colleagues.


Meeting Highlights

  • Keynote Presentation by Professor Stephen Evans of the London School of Hygiene & Tropical Medicine
  • Luncheon Roundtable Discussions
  • Tabletop Exhibits
  • Pre-meeting Tutorial Offerings

Who Should Attend 

Professionals with intermediate to advanced knowledge of, and experience in, clinical safety and who are involved in:

  • Pharmacovigilance
  • Drug safety
  • Risk management
  • Medical product safety assessment
  • Regulatory affairs
  • Clinical research
  • Data analysis
  • Pharmacoepidemiology
  • Medical information
  • Health outcomes

It is also designed for professionals who work for:

  • Industry: pharmaceuticals and biologics
  • Clinical Research Organizations
  • Academic Research Centers
  • Regulatory Agencies

Learning Objectives 

At the conclusion of this meeting, attendees will be able to:

  • Describe the current regulatory framework for pharmacovigilance in key markets
  • Discuss global implications of the Pharmacovigilance System Master File
  • Explain basic risk minimization interventions, measures of their effectiveness, and integration into selected health care systems
  • Describe new approaches for safety assessment of biosimilars in early clinical development
  • Examine the role of Real World Evidence in assessing product risk in the context of benefit
  • Discuss the impact of health literacy on risk communication

Special Offers 

Early Bird Registration
Industry Members save $200
Register by January 5, 2015

Group Discount Available!
Register 3 and Get the 4th Free!

Hotel & Travel 

Renaissance Washington DC Downtown Hotel
A limited number of rooms are available at the reduced rate shown below (rate is guaranteed until January 9, 2015, or until room block is filled).  Please note: In order to receive the reduced room rate, hotel reservations must be made with Travel Planners and not directly with the hotel.  Contact information for Travel Planners is as follows: Attendees can follow this link or call +1.212.532.1660 or 1.800.221.3531 in the U.S. When calling please select option 1 for “Hotel Reservations,” and inform the phone agent that you are making a reservation for Event #15002.

Standard Room Rate $195

Hotel Address: 999 Ninth Street NW Washington, DC 20001 USA

PLEASE READ
Warning:
Unauthorized Solicitation

The most convenient airport is Ronald Reagan Washington National Airport or Washington Dulles International Airport - attendees should make both airline and hotel reservations as early as possible.

 

Contact Information 

Printable Registration Form

Registration Questions
Toll Free 1.888.257.6457
Phone +1.215.442.6100
Fax +1.215.442.6199
Monday-Friday 8:30AM-8:00PM ET
CustomerService@diahome.org

Agenda Details
Rachel Minnick, Content Lead
Phone +1.215.442.6131
Fax +1.215.442.6199
Rachel.Minnick@diahome.org

Event Logistics
Ellen Diegel, Event Planner
Phone +1.215.293.5810
Fax +1.215.442.6199
Ellen.Diegel@diahome.org

Tabletop Exhibit
Jeff Korn, Exhibits Associate
Phone +1.215.442.6184
Fax +1.215.442.6199
Jeff.Korn@diahome.org

Program Committee 

Previous Next

Exhibits  

The Pharmacovigilance and Risk Management Strategies 2015 meeting offers interested companies the opportunity to exhibit with a tabletop display.

Tabletop Fee: $1,500

Fee Includes:

  • One six-foot skirted table
  • One chair
  • Standard electricity

Each tabletop rental requires at least one registered attendee to staff the table. All tabletop staff must be registered conference attendees.

Tabletop Exhibit Dates
January 26-28, 2015

Useful Links

  • DIA
  • Drug Safety Alliance
  • Medical Vigilance Solutions, Cincinnati Children’s
  • November Research Group
  • Online Business Applications
  • PPD
  • PROSAR
  • Quintiles
  • RxLogix Corporation
  • the Uppsala Monitoring Centre

Registration Fees 

Member

Charitable Nonprofit/Academia Member
$895.00
Member Government
$715.00
Member Industry
$1585.00
Member Industry (As of 01/06/2015)
$1785.00

Non-Member

Charitable Nonprofit/Academia Nonmember
$1120.00
NonMember Government
$940.00
NonMember Industry
$2010.00
Group Discounts

Register three individuals from the same company and receive complimentary registration for a fourth! All four individuals must register and prepay at the same time – no exceptions. DIA will apply the value of the lowest applicable fee to this complimentary registration; it does NOT include fees for optional events or DIA membership. You may substitute group participants of the same membership status at any time; however, administrative fees may be incurred.

Group registration is not available online and does not apply to the already-discounted fees for government or charitable nonprofit/academia. To take advantage of this offer, please print a registration form for EACH of the four registrants from your company. Include the names of all four group registrants on each of the forms and return them together to DIA.

Register Online

Unless otherwise disclosed, the statements made by speakers represent their own opinions and not necessarily those of the organization they represent, or that of the Drug Information Association. Speakers, agenda and CE information are subject to change without notice. Recording of any DIA educational material in any type of media is prohibited without prior written consent from DIA.

« Back to Listing Back To Top